{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:58:37Z","timestamp":1787029117509,"version":"build-2736575974"},"reference-count":53,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["2023ZB462"],"award-info":[{"award-number":["2023ZB462"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Neuromuscular blocking agents (NMBAs) are routinely used during anesthesia to relax skeletal muscle. Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels; NMBAs can induce muscle paralysis by preventing the neurotransmitter acetylcholine (ACh) from binding to nAChRs situated on the postsynaptic membranes. Despite widespread efforts, it is still a great challenge to find new NMBAs since the introduction of cisatracurium in 1995. In this work, an effective ensemble-based virtual screening method, including molecular property filters, 3D pharmacophore model, and molecular docking, was applied to discover potential NMBAs from the ZINC15 database. The results showed that screened hit compounds had better docking scores than the reference compound d-tubocurarine. In order to further investigate the binding modes between the hit compounds and nAChRs at simulated physiological conditions, the molecular dynamics simulation was performed. Deep analysis of the simulation results revealed that ZINC257459695 can stably bind to nAChRs\u2019 active sites and interact with the key residue Asp165. The binding free energies were also calculated for the obtained hits using the MM\/GBSA method. In silico ADMET calculations were performed to assess the pharmacokinetic properties of hit compounds in the human body. Overall, the identified ZINC257459695 may be a promising lead compound for developing new NMBAs as an adjunct to general anesthesia, necessitating further investigations.<\/jats:p>","DOI":"10.3390\/molecules29091955","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T05:26:13Z","timestamp":1714022773000},"page":"1955","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ensemble-Based Virtual Screening Led to the Discovery of Novel Lead Molecules as Potential NMBAs"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3440-1653","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Medicine, Nanjing University, Nanjing 210093, China"},{"name":"Jiangsu Key Laboratory of Central Nervous System Drug Research and Development, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonghui","family":"Ge","sequence":"additional","affiliation":[{"name":"School of Pharmacy, China Medical University, Shenyang 110122, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Xu","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Central Nervous System Drug Research and Development, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Medicine, Nanjing University, Nanjing 210093, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/ACO.0000000000000891","article-title":"The future of neuromuscular blocking agents","volume":"33","author":"Blobner","year":"2020","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2174\/0929867023369466","article-title":"Synthesis and structure-activity relationships of neuromuscular blocking agents","volume":"9","author":"Tuba","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4097\/kjae.2017.70.5.500","article-title":"Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents","volume":"70","author":"Kim","year":"2017","journal-title":"Korean J. Anesthesiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tran, D.T., Newton, E.K., Mount, V.A., Lee, J.S., Wells, G.A., and Perry, J.J. (2015). Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst. Rev., Cd002788.","DOI":"10.1002\/14651858.CD002788.pub3"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e202113235","DOI":"10.1002\/anie.202113235","article-title":"Template-Directed Synthesis of Bivalent, Broad-Spectrum Hosts for Neuromuscular Blocking Agents","volume":"61","author":"Selinger","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0163-7258(03)00030-5","article-title":"Conformation, action, and mechanism of action of neuromuscular blocking muscle relaxants","volume":"98","author":"Lee","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/1570159X19666210924092627","article-title":"Effects of Natural Products on Neuromuscular Junction","volume":"20","author":"Akkol","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrn731","article-title":"Emerging structure of the nicotinic acetylcholine receptors","volume":"3","author":"Karlin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0033583513000061","article-title":"Nicotinic acetylcholine receptor and the structural basis of neuromuscular transmission: Insights from Torpedo postsynaptic membranes","volume":"46","author":"Unwin","year":"2013","journal-title":"Q. Rev. Biophys."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12031-009-9248-x","article-title":"Postsynaptic development of the neuromuscular junction in mice lacking the gamma-subunit of muscle nicotinic acetylcholine receptor","volume":"40","author":"Liu","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/med.20036","article-title":"Development of ultra short-acting muscle relaxant agents: History, research strategies, and challenges","volume":"25","author":"Gyermek","year":"2005","journal-title":"Med. Res. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2014.12.006","article-title":"The nicotinic acetylcholine receptor and its prokaryotic homologues: Structure, conformational transitions & allosteric modulation","volume":"96","author":"Cecchini","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2016.09.096","article-title":"Thiadiazolodiazepine analogues as a new class of neuromuscular blocking agents: Synthesis, biological evaluation and molecular modeling study","volume":"126","author":"Hassan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2012.07.048","article-title":"16-morpholino quaternary ammonium steroidal derivatives as neuromuscular blocking agents: Synthesis, biological evaluation and in silico probe of ligand-receptor interaction","volume":"56","author":"Hu","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0749-0704(05)70187-1","article-title":"Neuromuscular-blocking drugs. Use and misuse in the intensive care unit","volume":"17","author":"Murphy","year":"2001","journal-title":"Crit. Care Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.accpm.2020.01.005","article-title":"Guidelines on muscle relaxants and reversal in anaesthesia","volume":"39","author":"Plaud","year":"2020","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/EJA.0000000000001194","article-title":"Rapid sequence induction: An international survey","volume":"37","author":"Klucka","year":"2020","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1034\/j.1399-6576.2000.440610.x","article-title":"Remifentanil and propofol without muscle relaxants or with different doses of rocuronium for tracheal intubation in outpatient anaesthesia","volume":"44","author":"Schlaich","year":"2000","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1007\/s00134-020-06297-8","article-title":"Myorelaxants in ARDS patients","volume":"46","author":"Hraiech","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/014860710302700127","article-title":"Effect of neuromuscular blockade on energy expenditure in patients with severe head injury","volume":"27","author":"McCall","year":"2003","journal-title":"JPEN J. Parenter Enter. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.resuscitation.2014.05.017","article-title":"Neuromuscular blockade during therapeutic hypothermia after cardiac arrest: Observational study of neurological and infectious outcomes","volume":"85","author":"Lascarrou","year":"2014","journal-title":"Resuscitation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/ALN.0000000000002408","article-title":"Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine","volume":"129","author":"Savarese","year":"2018","journal-title":"Anesthesiology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"112403","DOI":"10.1016\/j.ejmech.2020.112403","article-title":"Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups","volume":"200","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/cmdc.201800817","article-title":"Isomeric Carborane Neuromuscular Blocking Agents","volume":"14","author":"Goswami","year":"2019","journal-title":"ChemMedChem"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Blanes-Mira, C., Fern\u00e1ndez-Aguado, P., de Andr\u00e9s-L\u00f3pez, J., Fern\u00e1ndez-Carvajal, A., Ferrer-Montiel, A., and Fern\u00e1ndez-Ballester, G. (2022). Comprehensive Survey of Consensus Docking for High-Throughput Virtual Screening. Molecules, 28.","DOI":"10.3390\/molecules28010175"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1359-6446(02)02483-2","article-title":"Structure-based virtual screening: An overview","volume":"7","author":"Lyne","year":"2002","journal-title":"Drug Discov. Today"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.drudis.2011.02.011","article-title":"State-of-the-art in ligand-based virtual screening","volume":"16","author":"Ripphausen","year":"2011","journal-title":"Drug Discov. Today"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","article-title":"Pharmacophore modeling and applications in drug discovery: Challenges and recent advances","volume":"15","author":"Yang","year":"2010","journal-title":"Drug Discov. Today"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.2174\/138161207782794257","article-title":"Predictive QSAR modeling workflow, model applicability domains, and virtual screening","volume":"13","author":"Tropsha","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41594-022-00737-3","article-title":"Structural mechanism of muscle nicotinic receptor desensitization and block by curare","volume":"29","author":"Rahman","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molstruc.2019.04.042","article-title":"Activity of the rocuronium molecule and its derivatives: A theoretical calculation","volume":"1189","author":"Erkan","year":"2019","journal-title":"J. Mol. Struct."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1504\/IJBRA.2013.056076","article-title":"Receptor-based pharmacophore tool for design and development of next-generation drugs","volume":"9","author":"Udayakumar","year":"2013","journal-title":"Int. J. Bioinform. Res. Appl."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Almahmoud, S., Jin, W., Geng, L., Wang, J., Wang, X., Vennerstrom, J.L., and Zhong, H.A. (2020). Ligand-based design of GLUT inhibitors as potential antitumor agents. Bioorganic Med. Chem., 28.","DOI":"10.1016\/j.bmc.2020.115395"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12551-013-0130-2","article-title":"Receptor-ligand molecular docking","volume":"6","author":"Guedes","year":"2014","journal-title":"Biophys. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1006\/jmbi.1999.2721","article-title":"Nicotinic acetylcholine receptor at 4.6 A resolution: Transverse tunnels in the channel wall","volume":"288","author":"Miyazawa","year":"1999","journal-title":"J. Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Benoit, E., Couesnon, A., Lindovsky, J., Iorga, B.I., Ar\u00e1oz, R., Servent, D., Zakarian, A., and Molg\u00f3, J. (2019). Synthetic Pinnatoxins A and G Reversibly Block Mouse Skeletal Neuromuscular Transmission In Vivo and In Vitro. Mar. Drugs, 17.","DOI":"10.3390\/md17050306"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/07391102.2020.1817787","article-title":"Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: An in silico docking and molecular dynamics simulation approach","volume":"40","author":"Majumder","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1021\/acs.jcim.9b00300","article-title":"In Silico Prediction of Human Intravenous Pharmacokinetic Parameters with Improved Accuracy","volume":"59","author":"Wang","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ali, M.I., Thirukovela, N.S., Kumar, G.B., Dasari, G., Badithapuram, V., Manchal, R., and Bandari, S. (2024). Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline-isoxazole-piperazine conjugates as EGFR-targeting agents. Chem. Biol. Drug Des., 103.","DOI":"10.1111\/cbdd.14499"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"103470","DOI":"10.1016\/j.etap.2020.103470","article-title":"preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis?","volume":"80","author":"Filgueiras","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/156802608786786624","article-title":"Medicinal chemistry and the molecular operating environment (MOE): Application of QSAR and molecular docking to drug discovery","volume":"8","author":"Vilar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X","article-title":"MMFF VI. MMFF94s option for energy minimization studies","volume":"20","author":"Halgren","year":"1999","journal-title":"J. Comput. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13071-019-3341-y","article-title":"Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening","volume":"12","author":"Yin","year":"2019","journal-title":"Parasites Vectors"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10822-012-9570-1","article-title":"Variability in docking success rates due to dataset preparation","volume":"26","author":"Corbeil","year":"2012","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/pro.3997","article-title":"Templates for writing PyMOL scripts","volume":"30","author":"Mooers","year":"2021","journal-title":"Protein Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: Fast, flexible, and free","volume":"26","author":"Lindahl","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J. Comput. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"054112","DOI":"10.1063\/5.0040966","article-title":"A compression strategy for particle mesh Ewald theory","volume":"154","author":"Simmonett","year":"2021","journal-title":"J. Chem. Phys."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: Strategies and Applications in Drug Design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/9\/1955\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:33:34Z","timestamp":1760106814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/9\/1955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["molecules29091955"],"URL":"https:\/\/doi.org\/10.3390\/molecules29091955","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]}}}